Use of Recombinant Tissue-Type Plasminogen Activator to Treat Massive Pulmonary Embolism after Cesarean Section: A Case Report

Journal of Obstetrics and Gynaecology Research

Volumn 22, Issue 3, 1996, Pages 201-208

  Onoyama, Yoshimichi ^a,b   Minamitani, Makoto ^a   Takeuchi, Hajime ^a   Sakai, Sunao ^a   Eguchi, Hiroyuki ^a  

^a Shimonoseki City Hospital   (Japan)

^b MATSUYAMA RED CROSS HOSPITAL   (Japan)

Author keywords

Cesarean section; Hemorrhagic complication; Placental thrombus; Pulmonary embolism; Tissue type plasminogen activator

Indexed keywords

RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; FATALITY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; LUNG EMBOLISM; POSTOPERATIVE COMPLICATION; PREGNANCY; PUERPERAL DISORDER;

ADULT; CESAREAN SECTION; FATAL OUTCOME; FEMALE; HUMANS; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PUERPERAL DISORDERS; PULMONARY EMBOLISM; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030154826     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.1996.tb00967.x     Document Type: Article

References (18)

1. Bolan JC. Thromboembolic complications of pregnancy. Clin Obstet Gynecol 1983; 26: 913-922
2. Sipes SL, Weiner CP. Venous thromboembolic disease in pregnancy. Seminars in Perinatology 1990; 14: 103-118
3. Rutherford SE, Phelan JP. Deep venous thrombosis and pulmonary embolism in pregnancy. Obstet Gynecol Clin North Am 1991; 18: 345-370
4. Maternal & Child Health Division, Children & Families Bureau, Ministry of Health and Welfare, Japan eds. Maternal and Child Fealth Statistics of Japan. Tokyo: Mothers' & Children's Health Organization, 1993
5. Statistics and Information Department, Minister's Secretariat, Ministry of Health and Welfare, Japan. Vital Statistics of Japan 1988, 1989, 1990, 1991, 1992. Tokyo: Statistics and Information Department, Minister's Secretariat, Ministry of Health and Welfare, Japan
6. Poole J. Pulmonary embolism. NAACOG's Clinical Issues. 1992: 3: 461-468
7. Sakata Y. Kessenshoh. 1st ed. Tokyo: Chyugai Igakusha, 1994; 42-48 (in Japanese)
8. Prewitt RM, Hoy C, Kong A, Gu S, Greenberg D, Cook R, Chan M, Ducas J. Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator. Am Rev Respir Dis 1990 ; 141, 290-295
9. Topol EJ. Which thrombolytic agent should one choose? Prog Cardiov Dis 1991; 34: 165-178
10. Takishima T, Shirato K, Kitamura S, Yokoyama T, Kanazawa M, Kira S, Aiba M, Fukuchi Y, Nakano T, Kunieda T, Ogawa N. Single intravenous infusion of recombinant tissue-type plasminogen activator (TD-2061) in the treatment of pulmonary thromboembolism-A multicenter open clinical trial. Shindan to Chiryoh 1993; 81: 154-173 (in Japanese)
11. Flossdorf T, Breulmann M, Hopf HB. Successful treatment of massive pulmonary embolism with recombinant tissue type plasminogen activator (rt-PA) in a pregnant woman with intact gravidity and preterm labour. Intensive Care Med 1990; 16: 454-456
12. Baudo F, Caimi TM, Redaelli R, Nosari AM, Mauri M, Leonardi G, deCataldo F. Emergency treatment with recombinant tissue plasminogen activator of pulmonary embolism in a preganant woman with antithrombin III deficiency. Am J Obstet Gynecol 1990; 163: 1274-1275
13. Seifried E, Gabelmann A, Ellbruck, Schmidt A. Thrombolytic therapy of massive pulmonary embolism in early pregnancy with recombinant tissue-type plasminogen activator. Gebrutsh u Frauenheilk 1991; 51: 655-658
14. Takeda J, Ozawa H, Hiyama A, Shimada M, Ochiai R, Fukushima K. Three cases of lethal acute pulmonary embolism occurred early stage after operation. Rinshoh Masui 1991; 15: 517-518 (in Japanese)
15. The urokinase pulmonary embolism trial study group. Urokinase pulmonary embolism trial. Phase 1 results. JAMA 1970; 214: 2163-2172
16. A national cooperative study: The urokinase pulmonary embolism trial. Circulation 1973; 47 (Suppl. II): 1-12
17. Verstraete M, Miller GAH, Bounameaux H, Charbonnier B, Colle JP, Lecorf G, Marbet GA, Mombaerts P, Olsson CG. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988; 77: 353-360
18. Goldhaber SZ, Vaughan DE, Markis JE, et al. Acute pulmonary embolism treated with tissue plasminogen activator. Lancet 1986; 18: 886-889